Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

Frank J. Palella, Kathleen M. Delaney, Anne C. Moorman et al. · New England Journal of Medicine · 1998 · 9.5K citations

Public Health, Infectious Disease Control, Infectious Diseases +15

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Scott M. Hammer, Kathleen Squires, Michael D. Hughes et al. · New England Journal of Medicine · 1997 · 2.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway

Hiroaki Hemmi, Tsuneyasu Kaisho, Osamu Takeuchi et al. · Nature Immunology · 2002 · 2.5K citations

Life Sciences, Immunology, Pharmacology +16

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Janet D. Siliciano, Joleen Kajdas, Diana Finzi et al. · Nature Medicine · 2003 · 1.7K citations

Life Sciences, Immunology, Infectious Diseases +15

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response

Rob Roy MacGregor, Jean Boyer, Kenneth E. Ugen et al. · The Journal of Infectious Diseases · 1998 · 640 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17